Caption Management, LLC Cerevel Therapeutics Holdings, Inc. Put Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $10.1 Million - $11.1 Million
260,000 New
260,000 $10.6 Million
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $2.28 Million - $4.77 Million
112,500 New
112,500 $4.77 Million
Q2 2023

Aug 14, 2023
BUY
$23.9 - $35.38 $717,000 - $1.06 Million
30,000 New
30,000 $953,000
Q2 2022

Aug 15, 2022
BUY
$20.62 - $37.15 $668,088 - $1.2 Million
32,400 New
32,400 $857,000

Others Institutions Holding CERE

# of Institutions
9
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email